Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 8:29 PM ET

Healthcare Providers and Services

Company Overview of Eddingpharm (Cayman) Inc.

Company Overview

Eddingpharm (Cayman) Inc. operates as a pharmaceuticals marketing company. The company engages in in-licensing, marketing, and distributing hospital pharmaceutical products in Hong Kong and China. It offers nutritional supplements, oncology drugs, and other pharmaceuticals. The company also offers products including Telatinib, an anti-angiogenic for gastric and solid tumors, ACTB1003, a multi-mode oral kinase inhibitor, and ACTB1010, a mitotic Aurora kinase oral inhibitor. The company has a joint venture with Chiesi Farmaceutici S.p. A to establish Chiesi Edding Hong Kong Limited. Eddingpharm (Cayman) Inc. is based in Wanchai, Hong Kong.

Suite 4804

48/F Central Plaza

18 Harbour Road


Hong Kong


852 2877 4866


852 2877 4966

Key Executives for Eddingpharm (Cayman) Inc.

Founder, Chairman and Chief Executive Officer
Senior Vice President of Finance
Chief Operating Officer
Senior Vice President of Distribution
Director of Legal Department
Compensation as of Fiscal Year 2015.

Eddingpharm (Cayman) Inc. Key Developments

Faes Farma and Eddingpharm Form Joint Venture in China

Faes Farma has signed a deal with Eddingpharm (Hong Kong) for the establishment of a joint venture that allows the Spanish company to market its products in the Chinese market. Under the terms of the agreement, the products will be manufactured in Faes Farma plants and exported to China. The project is being initiated with local development and registration of four Faes Farma products in China.

Eddingpharm (Cayman) Inc. Presents at BioEquity Europe 2015, May-20-2015 11:30 AM

Eddingpharm (Cayman) Inc. Presents at BioEquity Europe 2015, May-20-2015 11:30 AM. Venue: InterContinental Vienna, Vienna, Austria. Speakers: Xiaoming Zou, CBO.

Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa (Icosapent Ethyl) in China

Amarin Corporation plc and Eddingpharm, announced an exclusive agreement for Eddingpharm to develop and commercialize Vascepa (icosapent ethyl) in the territories of the Mainland China, the Hong Kong and Macao Special Administrative Regions and Taiwan for uses that are currently commercialized and under development by Amarin in the United States based on the MARINE, ANCHOR and ongoing REDUCE-IT clinical trials of Vascepa. Under the agreement, Eddingpharm will be responsible for development and commercialization activities in the territory and associated expenses. Amarin will provide development assistance and be responsible for supplying finished, and later bulk, product. Terms of the agreement include up-front and milestone payments to Amarin of up to $169.0 million, including a non-refundable $15.0 million up-front payment and development, regulatory and sales-based milestone payments of up to an additional $154.0 million. Eddingpharm will also pay Amarin tiered double-digit percentage royalties on net sales of Vascepa in the territory escalating to the high teens. Amarin will supply product to Eddingpharm under negotiated supply terms.

Similar Private Companies By Industry

Company Name Region
Core Medical Technology Limited Asia
Phynova China Limited Asia
bodycure International Asia
Kinetik Medical Devices Limited Asia
ReachOut Holdings Limited Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eddingpharm (Cayman) Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at